Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD

• Graham S Hillis,
• Claudia C Dobler,
• Christine Jenkins,
• Ian A Yang,
• Jeremy Wrobel,
• Allison Martin,
• Robert J Hancox,
• Gian Luca Di Tanna,
• Belinda Cochrane,
• Catherina L Chang,
• Vanessa McDonald,
• Claude S Farah,
• Caroline Polak Scowcroft,
• Ashutosh Aggarwal,
• Grace Balicki,
• Shane Galgey

Affiliations

Graham S Hillis

Royal Perth Hospital, Perth, Western Australia, Australia

Claudia C Dobler

The George Institute for Global Health, Newtown, New South Wales, Australia

Christine Jenkins

The George Institute for Global Health, Newtown, New South Wales, Australia

Ian A Yang

The Prince Charles Hospital, Chermside, Queensland, Australia

Jeremy Wrobel

Fiona Stanley Hospital, Murdoch, Western Australia, Australia

Allison Martin

The George Institute for Global Health, Newtown, New South Wales, Australia

Robert J Hancox

University of Otago, Dunedin, New Zealand

Gian Luca Di Tanna

The George Institute for Global Health, Newtown, New South Wales, Australia

Belinda Cochrane

Campbelltown Hospital, Campbelltown, New South Wales, Australia

Catherina L Chang

Waikato Hospital, Hamilton, New Zealand

Vanessa McDonald

University of Newcastle, Callaghan, New South Wales, Australia

Claude S Farah

Concord Repatriation General Hospital, Concord, New South Wales, Australia

Caroline Polak Scowcroft

Consumer Representative, Canberra, ACT, Australia

Ashutosh Aggarwal

Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

Grace Balicki

The George Institute for Global Health, Newtown, New South Wales, Australia

Shane Galgey

The George Institute for Global Health, Newtown, New South Wales, Australia